Treatment with incretin-based weight-loss medications, like GLP-1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback